Bin Yang

发表

NADPH oxidase 2 mediates cardiac sympathetic denervation and myocyte autophagy, resulting in cardiac atrophy and dysfunction in doxorubicin-induced cardiomyopathy

Bao Li, F. Qin, Ke Wang, 2024, Scientific reports.

NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagy.

Bao Li, F. Qin, Li‐Guo Yang, 2024, European journal of pharmacology.